oons Market, Global, Revenue ($m), 2004-2011 40Figure 23: PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2011-2018 41Figure 24: Peripheral Vascular Devices Market, Global, Cross-country Analysis, CAGR (%), 2004-2018 42Figure 25: Peripheral Vascular Devices Market, the US, Revenue ($m), 2004-2011 43Figure 26: Peripheral Vascular Devices Market, the US, Revenue ($m), 2011-2018 45Figure 27: Peripheral Vascular Devices Market,
Canada, Revenue ($m), 2004-2011 46Figure 28: Peripheral Vascular Devices Market,
Canada, Revenue ($m), 2011-2018 48Figure 29: Peripheral Vascular Devices Market,
Germany, Revenue ($m), 2004-2011 49Figure 30: Peripheral Vascular Devices Market,
Germany, Revenue ($m), 2011-2018 50Figure 31: Peripheral Vascular Devices Market, the UK, Revenue ($m), 2004-2011 51Figure 32: Peripheral Vascular Devices Market, the UK, Revenue ($m), 2011-2018 52Figure 33: Peripheral Vascular Devices Market,
France, Revenue ($m), 2004-2011 53Figure 34: Peripheral Vascular Devices Market,
France, Revenue ($m), 2011-2018 54Figure 35: Peripheral Vascular Devices Market,
Italy, Revenue ($m), 2004-2011 55Figure 36: Peripheral Vascular Devices Market,
Italy, Revenue ($m), 2011-2018 56Figure 37: Peripheral Vascular Devices Market,
Spain, Revenue ($m), 2004-2011 57Figure 38: Peripheral Vascular Devices Market,
Spain, Revenue ($m), 2011-2018 59Figure 39: Peripheral Vascular Devices Market,
Brazil, Revenue ($m), 2004-2011 60Figure 40: Peripheral Vascular Devices Market,
Brazil, Revenue ($m), 2011-2018 61Figure 41: Peripheral Vascular Devices Market,
Japan, Revenue ($m), 2004-2011 62Figure 42: Peripheral Vascular Devices Market,
'/>"/>SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Related medicine technology :1.
Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy2.
Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan3.
Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 20184.
Global Peripheral Vascular Devices Market 2011-20155.
Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others6.
North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others7.
European Markets for Peripheral Vascular Devices 20128.
European Market for Peripheral Vascular Devices9.
Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market10.
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)11.
MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications